PET/CT hybrid imaging technique provides accurate guide for prostate cancer biopsy
PET and CT can be used together to image the physiology and structure of recurrent prostate cancer. Researchers have recently developed PET imaging that focuses on prostate-specific membrane antigen (PSMA). The surface of prostate cancer cells overexpresses PSMA.
PSMA can be detected if the disease spreads to other organs. By administering small doses of gallium-68 (68Ga), a radioactive material, and PSMA-HBED-CC before PET/CT scanning, imaging can detect PSMA with high accuracy. Read more.